Autor/in Blauvelt, A 2 Papp, K Reich, K Ferris, L K 1 Gooderham, M 1 Gordon, K B 1 Gottlieb, A 1 Jarell, A 1 Langley, R G 1 Lima, R G 1 Lowry, S 1 Maari, C 1 Mendelsohn, A 1 Parno, J 1 Sofen, H 1 Tada, Y 1 Tyring, S 1 Zhao, Y 1 alle zeigenListe einklappen
A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 12-week efficacy, safety and speed of response from a randomized, double-blinded trial Blauvelt, A Papp, K Gottlieb, A Jarell, A Reich, K Maari, C Gordon, K B 2020 - Forschungsinformationssystem des UKE
Tildrakizumab efficacy and impact on quality of life up to 52 weeks in patients with moderate-to-severe psoriasis: a pooled analysis of two randomized controlled trials Blauvelt, A Sofen, H Papp, K Gooderham, M Tyring, S Zhao, Y Lowry, S 2019 - Forschungsinformationssystem des UKE
